Doctor profile · Federal record

Dr. Michael Valitutto, DO

Internal Medicine Physician (CMS: Internal Medicine) · Kalamazoo, MI

  • NPI 1326074378
  • Accepts Medicare
  • MIPS 95.4 / 100 · 2023
  • 32 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
1717 Shaffer St, Ste 229
Kalamazoo, MI 490481647
(269) 226-8321
Mailing address
5943 Stadium Dr, Ste 3
Kalamazoo, MI 490093016

Credentials & registration

NPPES · NUCC
NPI registered
June 2006 — 20 yrs on file
Profile last updated
July 8, 2007
Year of graduation
1994 — 32 yrs since
Specialty taxonomy
207R00000X — NUCC code
State license (1)
Michigan #5101012365

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1326074378. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
1,037
Distinct HCPCS
4
Medicare allowed
$83,612
HCPCS Description Services Patients Avg allowed
99214 Established patient office or other outpatient visit, 30-39 minutes 593 298 $94
95251 Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report 315 132 $32
99215 Established patient office or other outpatient visit, 40-54 minutes 93 75 $138
99204 New patient office or other outpatient visit, 45-59 minutes 36 36 $132

In context: peer comparison

Among 57 peers in this city , average services per provider: 93. This provider delivers 11× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$252,573
Transactions
462
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Corcept Therapeutics 99 $77,349.97
Lilly USA, LLC 90 $56,042.32
Novo Nordisk Inc 60 $25,318.09
Amgen Inc. 39 $20,021.90
Boehringer Ingelheim Pharmaceuticals, Inc. 51 $17,644.77
Bayer Healthcare Pharmaceuticals Inc. 24 $14,323.57
GlaxoSmithKline, LLC. 1 $12,350.00
Insulet Corporation 58 $11,675.32
CeQur Corporation 3 $8,222.64
Madrigal Pharmaceuticals 12 $4,985.14
Abbott Laboratories 10 $3,878.35
Dexcom, Inc. 12 $262.80
AstraZeneca Pharmaceuticals LP 1 $100.00
Ascensia Diabetes Care Us Inc. 1 $98.02
Medtronic, Inc. 1 $88.98

By nature of payment

Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
$165,051
Travel and Lodging
$41,281
Consulting Fee
$18,463
Compensation for serving as faculty or as a speaker for a medical education program
$9,693
Honoraria
$9,370
Food and Beverage
$8,683
Education
$33

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
5,756
Patients
1,580
Total drug cost
$4,908,267
Drug Type Claims Patients Total cost
Ozempic (Semaglutide) Brand 665 155 $1,082,052
Metformin Hcl Generic 629 186 $11,472
Trulicity (Dulaglutide) Brand 612 136 $995,794
Jardiance (Empagliflozin) Brand 554 142 $641,912
Atorvastatin Calcium Generic 476 161 $9,975
Levothyroxine Sodium Generic 458 118 $8,114
Farxiga (Dapagliflozin Propanediol) Brand 376 76 $361,942
Novolog (Insulin Aspart) Brand 354 110 $575,967
Pioglitazone Hcl Generic 324 89 $12,057
Metformin Hcl Er (Metformin Hcl) Brand 270 90 $5,798

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Michael Valitutto's medical specialty?
Dr. Michael Valitutto practices Internal Medicine Physician in Kalamazoo, MI.
Where does Dr. Michael Valitutto practice?
Dr. Michael Valitutto practices at 1717 Shaffer St, Kalamazoo, MI 490481647. Office phone: 2692268321.
What is Dr. Michael Valitutto's NPI?
Dr. Michael Valitutto's National Provider Identifier (NPI) is 1326074378, issued by NPPES.
Does Dr. Michael Valitutto accept Medicare assignment?
Yes. Dr. Michael Valitutto accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Michael Valitutto commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report (HCPCS 95251); Established patient office or other outpatient visit (HCPCS 99215). Source: CMS Medicare Physician & Other Practitioners file.